Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Current Report Filing (8-k)
August 09 2021 - 04:07PM
Edgar (US Regulatory) ...
https://www.otcmarkets.com/filing/html?id=15147160&guid=LkD1k69wzo6Ylyh
I loaded 2 was ago
PDS Biotechnology to Present Recent Phase 2 Human Clinical Data and On-Going Oncology Programs at Investor Conferences
BTIG Investor Conference
Date: Tuesday, August 10, 2021
HC Wainwright 23rd Annual Global Investment Conference
Date: Tuesday, September 14, 2021
Cantor Healthcare Conference
Date: Monday, September 27, 2021
AGP Fall Virtual Biotech & Specialty Pharma Conference
Date: Wednesday, October 13, 2021
A separate press release will be issued once presentation times become available.
Nope its the 5 count on the ELLIOTT WAVE...s&p 500 near da top....Time to buy short index funds...
lol, their blaming it on the bond market yields and predicting a non stellar 2nd half of the year. But the Main stream media is pumping covid fear again so i think we can point the finger at them. I say keep it up. we have a few weeks till lift off
Not keeping up with reasons why, what did Biden do now?
Market’s going to get hammered today. Looking for cheapies
Good to see HEPA flying today, added to both yesterday and more PDS this morning.
LOLZzzzzzzzzzz! logged in to see whats going on. Must be Frank, The man can pull in some investors
where is the cream puff marshmallow lady gaging on sausages!
https://giphy.com/gifs/clown-slapstick-pie-in-the-face-KfI6Y0KhP2Rg6A3tzh
KABOOM
$PDSB
40 to 100 valuation in 2 to 3yrs mark post
Cantor Fitzgerald Initiates Coverage On PDS Biotechnology with Overweight Rating, Announces Price Target of $25
PDSB
Update on Brazil this week that trials have commenced would be money ball.
$PDSB
Thanks for the concern this is where I got my info!
According to yahoo finance PDSB is up 695%+ 52 week change at the moment.
All my shares are free and clear house money now.
https://finance.yahoo.com/quote/PDSB/key-statistics?p=PDSB
$PDSB
You are getting ahead of yourself, PDS is ONLY up 400% YTD, not 700%. Give it time, we will soon be saying much higher than 700%, just not yet.
PDSB one of the top performing stocks of 2021 up 700%
Let it do its thing it can take off on a moments notice & run like hell.
$PDSB
Yes & to answer your question on the PM not me.
Brazil news coming
$PDSB
CM LOADED 30K HERE
BIG AND BULLISH LONG TERM VERY BULLISH
http://www.stockta.com/cgi-bin/analysis.pl?symb=PDSB&cobrand=&mode=stock
You will lose a lot of money shorting it
This stock should and could be next reddit banger so much potential
Just reeled in another 5k lot I’m thirsty and hungry!
$PDSB
Some nice buys coming in pm
Wealth Creator only piss poor fruity clowns would short this stock.
PDSB up 735% year to date! and still climbing.
$PDSB
This is another feather in Frank’s cap.
80 million in cash now.
Enjoy the weekend!
$PDSB
Just another day at the office. Banking hard!
Operation Green Stakes.
Stock pickers market.
$PDSB
Recovering well here. Should be news out of Brazil any day.
$PDSB
GAP UP ^ ^ ^
And they bought in BIG!
SEVEN insiders bought during this raise of capital. Better hold on to every share you got. ALWAYS a good sign!!
PDS Biotechnology Corporation Announces Closing of Approximately $52 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares
https://finance.yahoo.com/news/pds-biotechnology-corporation-announces-closing-201500142.html
FLORHAM PARK, N.J., June 17, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotechnology" or the "Company"), a clinical-stage immunotherapy company developing a pipeline of novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced the closing of its previously announced underwritten public offering of 6,088,235 shares of common stock (inclusive of the 794,117 shares that were sold pursuant to the underwriter’s full exercise of its option to purchase additional shares of common stock) at a public offering price of $8.50 per share. Certain insiders, including certain members of the Company’s board of directors and executive officers, purchased shares of PDS Biotech common stock in the offering.
Weeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee
It’s go time again!
Destroy little Shorty & all circus clowns.
https://tenor.com/view/hello-bear-waving-friendly-bear-grizzly-bears-waving-gif-8647530
$PDSB
Fress states facts. What do you have to offer??? I've looked at your post's, seems your the pumper till you open a short position. A double agent. No wonder you have no followers. your pathetic
Fress is a pumper short this piggy
Really good to see that news
Insiders buying $350,000 as part of offering at $8.50. Very bullish IMO
Copy that Frank is a smart cookie!
$PDSB
I'm amazed at how well this held up. I did kinda think it would though. What i've been seeing on all the boards i read is that ppl were waiting for a chance to get in or add.
2,865,746 Buy's 2,917,484 Sell's ((EVERYBODY LOVES THIS STOCK))
Its for insiders load now itll march up 6 to 8 months to 40 to 50 range
Load now before its too late
Waiting till EOD to add....I think it may still head down today into tomorrow morning.... 26% haircut is pretty significant though.....
GLTA
$PDSB did an offering in the $1s and $2s and still hit $13. So I don’t see this stopping us on our March to $50
A poster on stocktwits not sure if it´s true...
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced the pricing of its previously announced underwritten public offering of 5,294,118 shares of its common stock at a public offering price of $8.50 per share. The gross proceeds to PDS Biotech, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $45.0 million. All of the shares of common stock to be sold in the offering are being offered by PDS Biotech. PDS Biotech has granted the underwriters a 30-day option to purchase up to an additional 794,117 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about June 17, 2021, subject to customary closing conditions.
Where are you getting the information for 5.29M shares?
Followers
|
49
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1582
|
Created
|
06/17/20
|
Type
|
Free
|
Moderators |
https://pdsbiotech.com/images/pdf/presentation/2021/march/PDSB_Corporate_Overview_-_March_11_2021_FINAL_1.pdf |
DEVELOPING POWERFUL, SAFE, VERSATILE IMMUNOTHERAPIES |
PDSB Versamune® T cell Platform. Our Versamune® platform trains the immune system to unleash a powerful targeted T-cell attack and could dramatically improve treatment and patient outcomes across the cancer spectrum. |
PDSB analyst coverage: |
SECOND GENERATION COVID-19 VACCINE PHASE 3 Q4 2021 PDSB $100.00 PRICE PER SHARE =2.2 BILLION MARKET CAP |
PDSB biz presentation 2021: PDSB White Paper: https://pdsbiotech.com/images/pdf/presentation/2021/Whitepaper-2021_v6.pdf PDSB Biotech preparing to initiate 3 CANCER Phase 2 clinical studies for lead candidate PDS0101: https://www.youtube.com/watch?v=iYZRmRmRtUI&t=2s OPPENHEIMER Annual Healthcare Conference MARCH 16TH 2021 https://wsw.com/webcast/oppenheimer9/register.aspx?conf=oppenheimer9&page=pdsb&url=https://wsw.com/webcast/oppenheimer9/pdsb/2708189 PDSB website: |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |